膝关节骨关节炎关节腔内注射透明质酸后的患者报告结局
该回顾性分析纳入2018年10月至2022年5月在运动医学与成人重建门诊接受关节腔内透明质酸注射的膝关节骨关节炎患者995例,评估不同分子量制剂及不同门诊来源的患者报告结局变化。结果显示不同分子量间各时间点PROMIS评分无差异,仅6个月活动度评分在运动医学组与成人重建组间及不同Kellgren-Lawrence分级间存在显著差异,多数时间点未达最小临床重要差异。
要点
- 995例膝关节骨关节炎患者接受关节腔内透明质酸注射并完成患者报告结局评估。
- 不同分子量透明质酸在6周、6个月和12个月的PROMIS评分无差异。
- 仅6个月活动度评分在运动医学组与成人重建组间及不同Kellgren-Lawrence分级间有显著差异。
核心结论
- PROMIS评分的平均变化仅在6个月活动度评分上因门诊来源和Kellgren-Lawrence分级而存在显著差异,但多数时间点未达到最小临床重要差异。
- 需要进一步研究以探讨是否在特定患者人群中观察到改善。
研究设计与样本
- 回顾性分析2018年10月至2022年5月在运动医学和成人重建门诊接受关节腔内透明质酸注射的膝关节骨关节炎患者。
- 共995例患者接受关节腔内透明质酸注射并完成患者报告结局评估。
- 使用单因素和多因素分析评估基线与随访期患者报告结局的变化以及运动医学与成人重建部门之间的差异。
主要发现
- 基于分子量,在6周、6个月和12个月时PROMIS各项评分无差异。
- 除6个月活动度评分在运动医学组与成人重建组间存在差异(-0.52 ± 5.46 对比 2.03 ± 6.95;P = .02)外,其余PROMIS评分均相似。
- 6个月活动度评分基于Kellgren和Lawrence分级存在显著差异(P = .005),但其余PROMIS评分均相似。
关键数值与推荐
- 患者报告结局测量信息系统(PROMIS)活动度、疼痛干扰和疼痛强度在基线、6周、6个月和12个月随访时完成。
- 6个月活动度评分在运动医学组与成人重建组间差异有统计学意义(P = .02)。
- 6个月活动度评分基于Kellgren和Lawrence分级差异有统计学意义(P = .005)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以探讨是否在特定患者人群中观察到改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intra-articular hyaluronic acid (IAHA) has been commonly used in the management of knee osteoarthritis (OA). This study sought to assess patient-reported outcomes (PRO) following different formulations of hyaluronic acid injections for patients who have knee OA. METHODS: A retrospective analysis was performed on patients who have knee OA and received IAHA knee injections from October 2018 to May 2022 in sports medicine (SM) and adult reconstructive (AR) clinics. Patients completed PRO measures including the Patient-Reported Outcome Measurement Information System (PROMIS) Mobility, Pain Interference, and Pain Intensity at baseline, 6-week, 6-month, and 12-month follow-up. Univariate and multivariate analyses were used to evaluate changes in PRO measures between baseline and follow-up periods and to evaluate differences between the SM and AR divisions. A total of 995 patients received IAHA for knee OA and completed PRO assessments. RESULTS: There was no difference in the PROMIS measures based on molecular weight at 6 weeks, 6 months, and 12 months. Except for 6-month Mobility scores between the SM and AR patients (-0.52 ± 5.46 versus 2.03 ± 6.95; P = .02), all other PROMIS scores were similar. Mobility scores at 6 months were significantly different based on Kellgren and Lawrence grade (P = .005), but all other PROMIS scores were similar. CONCLUSION: Average change in PROMIS scores were significantly different only for 6-month Mobility scores based on divisions and Kellgren and Lawrence grade but did not achieve minimally clinical important difference at most timepoints. Further studies are needed to investigate whether improvement is observed in specific patient populations.
引用
- Habibi AA, Karia RJ, Ward SA, et al. Patient-Reported Outcomes Following Intra-articular Hyaluronic Acid for Knee Osteoarthritis. J Arthroplasty. 2023. PMID: 37004967. doi:10.1016/j.arth.2023.03.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。